Health Care
Earnings preview: Medtronic could benefit from innovation, global expansion in Q3
Medical technology company Medtronic (MDT) will be reporting financial results for the third quarter Tuesday before the market opens. Analysts’…
Canopy Growth misses Q3 estimates
Canopy Growth (TSX: WEED, NYSE: CGC) reported a loss of CAD0.38 and revenue of CAD83 million, which missed analysts' predictions. Analysts…
Quest Diagnostics Q4 profit drops 50%, misses estimates
Quest Diagnostics (DGX) reported a 50% drop in earnings for the fourth quarter due to a decline in net revenues,…
Earnings: Oncology unit drives AstraZeneca topline higher in Q4
AstraZeneca Plc (AZN) reported a 22% dip in earnings for the fourth quarter to 82 cents per share, weighed down…
Johnson & Johnson buys Auris Health to boost medical devices business
Establishing its foray into robotic health products, pharmaceutical giant Johnson & Johnson (JNJ) on Wednesday announced it was acquiring California-based…
Gilead’s credibility takes a hit on massive NASH-drug failure, rivals jump
Shares of Gilead Sciences (GILD) have tumbled 20% in the past 52 weeks on numerous reasons including weaker-than-expected quarterly results…
Q3 Earnings Preview: Canopy Growth likely to continue its recent bullish momentum
Canopy Growth (TSX: WEED, NYSE: CGC) will release its financial results for the third fiscal quarter of 2019 after the…
Key comments from Aurora Cannabis (ACB) Q2 2019 earnings conference call
Aurora Cannabis (ACB) on Monday reported a loss of C$238 million in the second quarter of 2019, compared to a…